PROVENT Sleep Apnea Therapy:A Non-Invasive Treatment for Obstructive Sleep Apnea(OSA)

Monday, January 31st, 2011 at 10:16 PM

PROVENT Sleep Apnea Therapy is a simple, non-invasive treatment for OSA. PROVENT Therapy is a nightly-use prescription device attached with a hypoallergenic adhesive and placed over the nostrils. PROVENT Therapy works across mild, moderate, and severe OSA.

PROVENT Therapy utilizes a proprietary MicroValve technology developed by Ventus Medical. During inhalation, the valve opens allowing essentially normal airflow, and during exhalation, the valve closes, limiting airflow through two small openings, which increases expiratory pressure, helping to keep the airway open.

PROVENT Therapy has several advantages. It is easy to use, discreet and portable, powered by the patient’s own breathing (no electricity required), simple, and

Important Information About PROVENT Sleep Apnea Therapy

PROVENT Therapy is indicated for the treatment of obstructive sleep apnea. PROVENT Therapy is a prescription-only product and should be used only after consultation with a physician.

The PROVENT Nasal Device should not be used if you have any of the following conditions:

• A severe breathing disorder (including respiratory muscle weakness, bullous lung disease, bypassed upper airway, pneumothorax, pneumomediastinum, etc.)

• Severe heart disease (including heart failure)

• Pathologically low blood pressure

• An acute upper respiratory (including nasal, sinus, or middle ear) inflammation or infection, or perforation of the ear drum.

About Ventus Medical

Ventus Medical is a medical device company focused on improving the lives of patients with sleep-disordered breathing. Located in Belmont, California, Ventus Medical has developed and markets PROVENT Therapy, an innovative, clinically-proven treatment for OSA. Existing OSA solutions do not always meet patients’ needs. Through truly innovative technology, solid clinical evidence, and a focus on the patient, Ventus Medical seeks to deliver consumer-preferred, physician-recommended solutions. The company is privately-held and funded by De Novo Ventures, Mohr Davidow Ventures, and Johnson & Johnson Development Corporation.